FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2119660112> ?p ?o ?g. }

• W2119660112 abstract "Peripheral intravenous device (IVD) complications were traditionally thought to be reduced by limiting dwell time. Current recommendations are to resite IVDs by 96 hours with the exception of children and patients with poor veins. Recent evidence suggests routine resite is unnecessary, at least if devices are inserted by a specialised IV team. The aim of this study was to compare the impact of peripheral IVD 'routine resite' with 'removal on clinical indication' on IVD complications in a general hospital without an IV team. A randomised, controlled trial was conducted in a regional teaching hospital. After ethics approval, 362 patients (603 IVDs) were randomised to have IVDs replaced on clinical indication (185 patients) or routine change every 3 days (177 patients). IVDs were inserted and managed by the general hospital medical and nursing staff; there was no IV team. The primary endpoint was a composite of IVD complications: phlebitis, infiltration, occlusion, accidental removal, local infection, and device-related bloodstream infection. IVD complication rates were 68 per 1,000 IVD days (clinically indicated) and 66 per 1,000 IVD days (routine replacement) (P = 0.86; HR 1.03; 95% CI, 0.74-1.43). Time to first complication per patient did not differ between groups (KM with log rank, P = 0.53). There were no local infections or IVD-related bloodstream infections in either group. IV therapy duration did not differ between groups (P = 0.22), but more (P = 0.004) IVDs were placed per patient in the routine replacement (mean, 1.8) than the clinical indication group (mean, 1.5), with significantly higher hospital costs per patient (P < 0.001). Resite on clinical indication would allow one in two patients to have a single cannula per course of IV treatment, as opposed to one in five patients managed with routine resite; overall complication rates appear similar. Clinically indicated resite would achieve savings in equipment, staff time and patient discomfort. There is growing evidence to support the extended use of peripheral IVDs with removal only on clinical indication. Australian New Zealand Clinical Trials Registry (ANZCTR) Number ACTRN12608000421336." @default.
• W2119660112 created "2016-06-24" @default.
• W2119660112 creator A5032075950 @default.
• W2119660112 creator A5048749306 @default.
• W2119660112 creator A5072046447 @default.
• W2119660112 creator A5086220162 @default.
• W2119660112 date "2010-09-10" @default.
• W2119660112 modified "2023-10-08" @default.
• W2119660112 title "Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial" @default.
• W2119660112 cites W111630495 @default.
• W2119660112 cites W1968106809 @default.
• W2119660112 cites W1995284768 @default.
• W2119660112 cites W2009735865 @default.
• W2119660112 cites W2010274658 @default.
• W2119660112 cites W2013975703 @default.
• W2119660112 cites W2017391137 @default.
• W2119660112 cites W2037746596 @default.
• W2119660112 cites W2045059949 @default.
• W2119660112 cites W2052345761 @default.
• W2119660112 cites W2057185077 @default.
• W2119660112 cites W2059172540 @default.
• W2119660112 cites W2062164437 @default.
• W2119660112 cites W2075704058 @default.
• W2119660112 cites W2075901402 @default.
• W2119660112 cites W2085986887 @default.
• W2119660112 cites W2088875727 @default.
• W2119660112 cites W2104851340 @default.
• W2119660112 cites W2113028472 @default.
• W2119660112 cites W2118596135 @default.
• W2119660112 cites W2122118861 @default.
• W2119660112 cites W2129202342 @default.
• W2119660112 cites W2145159920 @default.
• W2119660112 cites W2257933825 @default.
• W2119660112 cites W2317221179 @default.
• W2119660112 cites W2413509548 @default.
• W2119660112 cites W2625320817 @default.
• W2119660112 cites W4236770311 @default.
• W2119660112 doi "https://doi.org/10.1186/1741-7015-8-53" @default.
• W2119660112 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2944158" @default.
• W2119660112 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20831782" @default.
• W2119660112 hasPublicationYear "2010" @default.
• W2119660112 type Work @default.
• W2119660112 sameAs 2119660112 @default.
• W2119660112 citedByCount "124" @default.
• W2119660112 countsByYear W21196601122012 @default.
• W2119660112 countsByYear W21196601122013 @default.
• W2119660112 countsByYear W21196601122014 @default.
• W2119660112 countsByYear W21196601122015 @default.
• W2119660112 countsByYear W21196601122016 @default.
• W2119660112 countsByYear W21196601122017 @default.
• W2119660112 countsByYear W21196601122018 @default.
• W2119660112 countsByYear W21196601122019 @default.
• W2119660112 countsByYear W21196601122020 @default.
• W2119660112 countsByYear W21196601122021 @default.
• W2119660112 countsByYear W21196601122022 @default.
• W2119660112 countsByYear W21196601122023 @default.
• W2119660112 crossrefType "journal-article" @default.
• W2119660112 hasAuthorship W2119660112A5032075950 @default.
• W2119660112 hasAuthorship W2119660112A5048749306 @default.
• W2119660112 hasAuthorship W2119660112A5072046447 @default.
• W2119660112 hasAuthorship W2119660112A5086220162 @default.
• W2119660112 hasBestOaLocation W21196601121 @default.
• W2119660112 hasConcept C121332964 @default.
• W2119660112 hasConcept C126322002 @default.
• W2119660112 hasConcept C126965237 @default.
• W2119660112 hasConcept C127413603 @default.
• W2119660112 hasConcept C141071460 @default.
• W2119660112 hasConcept C168563851 @default.
• W2119660112 hasConcept C188198153 @default.
• W2119660112 hasConcept C203092338 @default.
• W2119660112 hasConcept C24890656 @default.
• W2119660112 hasConcept C3018946976 @default.
• W2119660112 hasConcept C535046627 @default.
• W2119660112 hasConcept C71924100 @default.
• W2119660112 hasConcept C78519656 @default.
• W2119660112 hasConcept C81182388 @default.
• W2119660112 hasConceptScore W2119660112C121332964 @default.
• W2119660112 hasConceptScore W2119660112C126322002 @default.
• W2119660112 hasConceptScore W2119660112C126965237 @default.
• W2119660112 hasConceptScore W2119660112C127413603 @default.
• W2119660112 hasConceptScore W2119660112C141071460 @default.
• W2119660112 hasConceptScore W2119660112C168563851 @default.
• W2119660112 hasConceptScore W2119660112C188198153 @default.
• W2119660112 hasConceptScore W2119660112C203092338 @default.
• W2119660112 hasConceptScore W2119660112C24890656 @default.
• W2119660112 hasConceptScore W2119660112C3018946976 @default.
• W2119660112 hasConceptScore W2119660112C535046627 @default.
• W2119660112 hasConceptScore W2119660112C71924100 @default.
• W2119660112 hasConceptScore W2119660112C78519656 @default.
• W2119660112 hasConceptScore W2119660112C81182388 @default.
• W2119660112 hasIssue "1" @default.
• W2119660112 hasLocation W21196601121 @default.
• W2119660112 hasLocation W21196601122 @default.
• W2119660112 hasLocation W21196601123 @default.
• W2119660112 hasLocation W21196601124 @default.
• W2119660112 hasLocation W21196601125 @default.
• W2119660112 hasLocation W21196601126 @default.
• W2119660112 hasOpenAccess W2119660112 @default.
• W2119660112 hasPrimaryLocation W21196601121 @default.
• W2119660112 hasRelatedWork W1974741395 @default.

• next